These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29127534)

  • 1. 'Test and Treat' Among Women at High Risk for HIV-infection in Kampala, Uganda: Antiretroviral Therapy Initiation and Associated Factors.
    Mayanja Y; Kamacooko O; Bagiire D; Namale G; Kaleebu P; Seeley J
    AIDS Behav; 2018 Mar; 22(3):1053-1061. PubMed ID: 29127534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test and treat: the early experiences in a clinic serving women at high risk of HIV infection in Kampala.
    Mbonye M; Seeley J; Nalugya R; Kiwanuka T; Bagiire D; Mugyenyi M; Namale G; Mayanja Y; Kamali A
    AIDS Care; 2016; 28 Suppl 3():33-8. PubMed ID: 27421050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of lost to follow-up in a "test and treat" programme among adult women with high-risk sexual behavior in Kampala, Uganda.
    Kamacooko O; Mayanja Y; Bagiire D; Namale G; Hansen CH; Seeley J
    BMC Public Health; 2020 Mar; 20(1):353. PubMed ID: 32183759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
    Boyer S; Iwuji C; Gosset A; Protopopescu C; Okesola N; Plazy M; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J;
    AIDS Care; 2016; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained virological response and drug resistance among female sex workers living with HIV on antiretroviral therapy in Kampala, Uganda: a cross-sectional study.
    Namale G; Kamacooko O; Bagiire D; Mayanja Y; Abaasa A; Kilembe W; Price M; Ssemwanga D; Lunkuse S; Nanyonjo M; Ssenyonga W; Mayaud P; Newton R; Kaleebu P; Seeley J
    Sex Transm Infect; 2019 Sep; 95(6):405-411. PubMed ID: 31266818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and predictors of pregnancy among a cohort of HIV-positive women initiating antiretroviral therapy in Mbarara, Uganda.
    Kaida A; Matthews LT; Kanters S; Kabakyenga J; Muzoora C; Mocello AR; Martin JN; Hunt P; Haberer J; Hogg RS; Bangsberg DR
    PLoS One; 2013; 8(5):e63411. PubMed ID: 23704906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-level viral suppression among pregnant and postpartum women in a universal test and treat trial.
    Kabami J; Balzer LB; Saddiki H; Ayieko J; Kwarisiima D; Atukunda M; Charlebois ED; Clark TD; Koss CA; Ruel T; Bukusi EA; Cohen CR; Musoke P; Petersen ML; Havlir DV; Kamya MR; Chamie G
    AIDS; 2020 Jul; 34(9):1407-1415. PubMed ID: 32472768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009.
    Geng EH; Hunt PW; Diero LO; Kimaiyo S; Somi GR; Okong P; Bangsberg DR; Bwana MB; Cohen CR; Otieno JA; Wabwire D; Elul B; Nash D; Easterbrook PJ; Braitstein P; Musick BS; Martin JN; Yiannoutsos CT; Wools-Kaloustian K
    J Int AIDS Soc; 2011 Sep; 14():46. PubMed ID: 21955541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual behaviors over a 3-year period among individuals with advanced HIV/AIDS receiving antiretroviral therapy in an urban HIV clinic in Kampala, Uganda.
    Wandera B; Kamya MR; Castelnuovo B; Kiragga A; Kambugu A; Wanyama JN; Easterbrook P; Sethi AK
    J Acquir Immune Defic Syndr; 2011 May; 57(1):62-8. PubMed ID: 21297481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
    Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
    Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland.
    Kekitiinwa A; Lee KJ; Walker AS; Maganda A; Doerholt K; Kitaka SB; Asiimwe A; Judd A; Musoke P; Gibb DM; ;
    J Acquir Immune Defic Syndr; 2008 Dec; 49(4):384-92. PubMed ID: 18931630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study.
    Kiyingi M; Nankabirwa JI; Sekaggya-Wiltshire C; Nangendo J; Kiweewa JM; Katahoire AR; Semitala FC
    BMC Health Serv Res; 2023 Jan; 23(1):40. PubMed ID: 36647104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-retroviral therapy scale-up and its impact on sex-stratified tuberculosis notification trends in Uganda.
    Zawedde-Muyanja S; Manabe YC; Musaazi J; Mugabe FR; Ross JM; Hermans S
    J Int AIDS Soc; 2019 Sep; 22(9):e25394. PubMed ID: 31529618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disinhibition in risky sexual behavior in men, but not women, during four years of antiretroviral therapy in rural, southwestern Uganda.
    Kembabazi A; Bajunirwe F; Hunt PW; Martin JN; Muzoora C; Haberer JE; Bangsberg DR; Siedner MJ
    PLoS One; 2013; 8(7):e69634. PubMed ID: 23894514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to HIV antiretroviral therapy among pregnant and postpartum women during the Option B+ era: 12-month cohort study in urban South Africa and rural Uganda.
    Matthews LT; Orrell C; Bwana MB; Tsai AC; Psaros C; Asiimwe S; Amanyire G; Musinguzi N; Bell K; Bangsberg DR; Haberer JE;
    J Int AIDS Soc; 2020 Aug; 23(8):e25586. PubMed ID: 32820622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults.
    Nachega JB; Mutamba B; Basangwa D; Nguyen H; Dowdy DW; Mills EJ; Katabira E; Nakimuli-Mpungu E
    Trop Med Int Health; 2013 Jan; 18(1):53-7. PubMed ID: 23136882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.
    Hamers RL; Wallis CL; Kityo C; Siwale M; Mandaliya K; Conradie F; Botes ME; Wellington M; Osibogun A; Sigaloff KC; Nankya I; Schuurman R; Wit FW; Stevens WS; van Vugt M; de Wit TF;
    Lancet Infect Dis; 2011 Oct; 11(10):750-9. PubMed ID: 21802367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression, alcohol use, and stigma in younger versus older HIV-infected pregnant women initiating antiretroviral therapy in Cape Town, South Africa.
    Wong M; Myer L; Zerbe A; Phillips T; Petro G; Mellins CA; Remien RH; Shiau S; Brittain K; Abrams EJ
    Arch Womens Ment Health; 2017 Feb; 20(1):149-159. PubMed ID: 27815628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons for test and treat in an antiretroviral programme after decentralisation in Uganda: a retrospective analysis of outcomes in public healthcare facilities within the Lablite project.
    Kiwuwa-Muyingo S; Abongomera G; Mambule I; Senjovu D; Katabira E; Kityo C; Gibb DM; Ford D; Seeley J
    Int Health; 2020 Sep; 12(5):429-443. PubMed ID: 31730168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.